U.S. Physical Therapy Inc...

NYSE: USPH · Real-Time Price · USD
74.33
-0.66 (-0.88%)
At close: Jun 02, 2025, 3:59 PM
74.19
-0.20%
After-hours: Jun 02, 2025, 04:04 PM EDT

U.S. Physical Therapy Revenue Breakdown

Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Net Patient Revenues Revenue 560.55M 514.56M 464.59M 438.33M 373.34M 433.35M 417.7M
Net Patient Revenues Revenue Growth +8.94% +10.75% +5.99% +17.41% -13.85% +3.74% n/a
Other Revenues Including Management Contract Revenues and Industrial Injury Prevention Services Revenues Revenue 110.79M 90.25M n/a n/a n/a n/a n/a
Other Revenues Including Management Contract Revenues and Industrial Injury Prevention Services Revenues Revenue Growth +22.77% n/a n/a n/a n/a n/a n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue n/a 17.99M 16.11M 11.45M 15.71M 11.36M 9.61M 12.14M 13.86M 11.93M 11.89M 10.74M 11.56M 10.72M 12.87M 12.07M 10.87M 10.92M 10.42M 9.02M 11.68M 11.67M 10.56M 11.53M 11.29M 10.41M 10.64M 10.13M 10.16M 10.18M 8.3M 8.86M 8.55M 7.84M 7.61M 8.03M 9M 8.89M 6.92M 7.59M 7.66M
Selling, General, and Administrative Revenue Growth -100.00% +11.69% +40.64% -27.11% +38.31% +18.26% -20.91% -12.37% +16.22% +0.30% +10.69% -7.05% +7.82% -16.70% +6.57% +11.04% -0.38% +4.74% +15.52% -22.74% +0.03% +10.58% -8.42% +2.07% +8.43% -2.14% +5.08% -0.34% -0.19% +22.62% -6.23% +3.62% +9.03% +3.01% -5.18% -10.86% +1.24% +28.47% -8.82% -0.84% n/a
Research and Development Revenue n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Research and Development Revenue Growth n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a